Menu
Not yet recruiting NCT07738133

Mechanisms Underlying Late-Life Prolonged Grief Disorder

No phase Interventional Prolonged Grief Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Iyengar Yoga, Health Education Control, Waitlist Control to Crossover.
Who it may be relevant to
Registry conditions: Prolonged Grief Disorder. Basic parameters: 40 years — 89 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Probing Brain Network Mechanisms Underlying Late-Life Prolonged Grief Disorder

Overview

After losing a loved one, most successfully navigate acute grief and adapt to the loss within about 1 year, but in about 10%, prolonged grief disorder (PGD) ensues. This study is anticipated to provide novel evidence regarding the neurobiological mechanisms of PGD in older adults. The biological alterations identified here could provide targets to elucidate how currently available therapies work and inform novel mechanism-based interventions for treating late-life PGD.

Detailed description

The objectives of this study are to (1) identify functional brain network features that differentiate PGD from integrated grief, and (2) conduct a mechanistic study in older adults with PGD to test whether exposure to 10-weeks of IY and HE modulate brain network targets and clarify how network changes relate to clinical response.

Interventions

  • Behavioral Iyengar Yoga
    Participants will engage in 10 weekly IY classes
  • Behavioral Health Education Control
    Participants will engage in 10 weekly socialization control group sessions
  • Other Waitlist Control to Crossover
    Upon Step 1 study completion (week 10), participants in this group who continue to meet PGD criteria on the SCIP will enter Step 2 phase

Primary outcome measures

  • Score on the Prolonged Grief 13-Revised (PG-13-R) scale [Time frame: Baseline through study completion, up to 10 weeks]

Eligibility criteria

Inclusion criteria

  • Male or female greater than or equal to 40 years of age
  • Bereavement >6 months
  • Score greater than or equal to 25 on the Inventory of Complicated Grief (ICG)
  • Presence of PGD (subsyndromal and syndromal)
  • Adequate visual and auditory acuity

Exclusion criteria

  • Delirium/unstable medical conditions
  • Lifetime history of neurological illnesses: seizures, stroke, dementia of any -etiology, severe head injury, brain tumor or surgery
  • Serious back, joint or neck injuries within the past 3 months
  • Currently practicing yoga
  • Gross structural abnormalities on T1-weighted images
  • Lifetime history of the following psychiatric disorders: bipolar or psychotic -disorders, including psychotic depression
  • Current alcohol/drug abuse or dependence
  • Magnetic resonance imaging (MRI) contraindications
  • Acute suicidality

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Other

Study locations

United States · 1 center
  • Medical College of Wisconsin — Milwaukee

Identifiers

NCT: NCT07738133 · PRO59299

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗